[HTML][HTML] Targeting PI3K/AKT signaling pathway in obesity
MS Savova, LV Mihaylova, D Tews, M Wabitsch… - Biomedicine & …, 2023 - Elsevier
Obesity is a disorder with an increasing prevalence, which impairs the life quality of patients
and intensifies societal health care costs. The development of safe and innovative …
and intensifies societal health care costs. The development of safe and innovative …
Lymphatic anomalies in children: update on imaging diagnosis, genetics, and treatment
Please see the Editorial Comment by Geetika Khanna discussing this article. Please see the
Author Video associated with this article. Lymphatic anomalies comprise a spectrum of …
Author Video associated with this article. Lymphatic anomalies comprise a spectrum of …
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
G Morin, C Degrugillier-Chopinet, M Vincent… - Journal of Experimental …, 2022 - rupress.org
PIK3CA-related overgrowth spectrum (PROS) includes rare genetic conditions due to gain-
of-function mutations in the PIK3CA gene. There is no approved medical therapy for patients …
of-function mutations in the PIK3CA gene. There is no approved medical therapy for patients …
[HTML][HTML] Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
TL Wenger, S Ganti, C Bull, E Lutsky, JT Bennett… - Genetics in …, 2022 - Elsevier
Purpose PIK3CA-related overgrowth spectrum (PROS) conditions of the head and neck are
treatment challenges. Traditionally, these conditions require multiple invasive interventions …
treatment challenges. Traditionally, these conditions require multiple invasive interventions …
[HTML][HTML] Drug repurposing for rare: progress and opportunities for the rare disease community
AH Jonker, D O'Connor, M Cavaller-Bellaubi… - Frontiers in …, 2024 - frontiersin.org
Repurposing is one of the key opportunities to address the unmet rare diseases therapeutic
need. Based on cases of drug repurposing in small population conditions, and previous …
need. Based on cases of drug repurposing in small population conditions, and previous …
When, where and which PIK3CA mutations are pathogenic in congenital disorders
A Angulo-Urarte, M Graupera - Nature Cardiovascular Research, 2022 - nature.com
PIK3CA encodes the class I PI3Kα isoform and is frequently mutated in cancer. Activating
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …
Alpelisib to treat CLOVES syndrome, a member of the PIK3CA‐related overgrowth syndrome spectrum
G Garreta Fontelles, J Pardo Pastor… - British Journal of …, 2022 - Wiley Online Library
CLOVES syndrome is a rare congenital overgrowth disorder caused by mutations in the
phosphatidylinositol 3‐kinase catalytic subunit alpha (PIK3CA) gene. It is part of the PIK3CA …
phosphatidylinositol 3‐kinase catalytic subunit alpha (PIK3CA) gene. It is part of the PIK3CA …
[HTML][HTML] Lateralized and segmental overgrowth in children
A Mussa, D Carli, S Cardaropoli, GB Ferrero, N Resta - Cancers, 2021 - mdpi.com
Simple Summary Congenital lateralized or segmental overgrowth (LO) disorders are
conditions characterized by excessive tissue growth of a body region often associated with a …
conditions characterized by excessive tissue growth of a body region often associated with a …
[HTML][HTML] Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific reports, 2023 - nature.com
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
[HTML][HTML] The genetic architecture of vascular anomalies: current data and future therapeutic perspectives correlated with molecular mechanisms
Vascular anomalies (VAs) are morphogenesis defects of the vascular system (arteries,
capillaries, veins, lymphatic vessels) singularly or in complex combinations, sometimes with …
capillaries, veins, lymphatic vessels) singularly or in complex combinations, sometimes with …